Dr. Daniel Roney, M.D

NPI: 1487618690
Total Payments
$14,346
2024 Payments
$2,144
Companies
79
Transactions
971
Medicare Patients
5,039
Medicare Billing
$378,364

Payment Breakdown by Category

Food & Beverage$14,270 (99.5%)
Education$75.92 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,270 959 99.5%
Education $75.92 12 0.5%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,676 93 $0 (2024)
ABBVIE INC. $1,359 76 $0 (2024)
PFIZER INC. $1,245 111 $0 (2024)
Novo Nordisk Inc $1,241 89 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,087 79 $0 (2024)
Lilly USA, LLC $751.16 54 $0 (2024)
Janssen Pharmaceuticals, Inc $572.29 47 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $503.99 28 $0 (2024)
GlaxoSmithKline, LLC. $466.31 32 $0 (2024)
Merck Sharp & Dohme LLC $453.82 34 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,144 119 ABBVIE INC. ($287.68)
2023 $2,019 114 AbbVie Inc. ($359.47)
2022 $1,820 117 ABBVIE INC. ($224.13)
2021 $2,187 139 AbbVie Inc. ($410.94)
2020 $1,568 96 AstraZeneca Pharmaceuticals LP ($305.86)
2019 $1,266 91 PFIZER INC. ($289.16)
2018 $1,654 139 PFIZER INC. ($254.80)
2017 $1,689 156 AstraZeneca Pharmaceuticals LP ($194.57)

All Payment Transactions

971 individual payment records from CMS Open Payments — Page 1 of 39

Date Company Product Nature Form Amount Type
12/30/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $7.76 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/18/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $20.28 General
Category: Diabetes Care
12/17/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $15.24 General
Category: PSYCHIATRY
12/10/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $18.50 General
Category: Diabetes
12/09/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $14.41 General
Category: TESTOSTERONE REPLACEMENT THERAPY
12/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.74 General
Category: NEUROSCIENCE
12/05/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $21.05 General
Category: Biological
12/03/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $12.76 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/02/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.30 General
Category: Respiratory
11/25/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $12.94 General
Category: PAIN
11/22/2024 Nevro Corp. Senza (Device) Food and Beverage In-kind items and services $24.64 General
Category: Spinal Cord Stimulator
11/21/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $20.51 General
Category: PSYCHIATRY
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $13.45 General
Category: Gastroenterology
11/18/2024 PFIZER INC. PAXLOVID (Drug), NURTEC ODT Food and Beverage In-kind items and services $14.79 General
Category: INFECTIOUS DISEASES
11/14/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $17.48 General
Category: Neurology
11/12/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.58 General
Category: Diabetes
11/08/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $18.78 General
Category: Anticholinergics, Inhaled
11/06/2024 IBSA Pharma Inc. Tirosint (Drug), Licart Food and Beverage Cash or cash equivalent $19.69 General
Category: Endocrinology
11/04/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $17.50 General
Category: GASTROENTEROLOGY
10/31/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.38 General
Category: PAIN
10/30/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $19.10 General
Category: Obesity
10/29/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.35 General
Category: Respiratory
10/28/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $11.98 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.77 General
Category: NEUROSCIENCE
10/16/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $20.00 General
Category: VACCINES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 1,029 1,479 $272,267 $70,857
2022 20 1,155 1,652 $309,233 $79,133
2021 21 1,204 1,722 $229,665 $108,628
2020 29 1,651 2,255 $254,086 $119,746
Total Patients
5,039
Total Services
7,108
Medicare Billing
$378,364
Procedure Codes
87

All Medicare Procedures & Services

87 procedure records from CMS Medicare Utilization — Page 2 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 13 13 $2,730 $2,125 77.8%
99217 Hospital observation care on day of discharge Facility 2022 30 34 $7,446 $1,835 24.6%
99495 Transitional care management services for problem of moderate complexity Office 2022 29 29 $8,381 $1,746 20.8%
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free Office 2022 52 52 $2,704 $1,640 60.6%
99225 Follow-up observation care per day, typically 25 minutes Facility 2022 20 28 $5,348 $1,492 27.9%
G0008 Administration of influenza virus vaccine Office 2022 52 52 $2,080 $1,488 71.6%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 12 12 $4,272 $1,227 28.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 27 29 $2,871 $1,098 38.2%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 18 33 $3,696 $986.53 26.7%
83036 Hemoglobin a1c level Office 2022 49 66 $1,320 $632.13 47.9%
81002 Urinalysis, manual test Office 2022 34 35 $595.00 $120.29 20.2%
G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report Office 2022 14 14 $406.00 $65.30 16.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 171 171 $32,319 $22,185 68.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 277 471 $59,838 $18,500 30.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 180 251 $38,159 $15,681 41.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 47 218 $22,784 $12,313 54.0%
99496 Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge Office 2021 35 37 $13,172 $8,121 61.7%
99495 Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge Office 2021 32 37 $10,693 $5,702 53.3%
99220 Hospital observation care, typically 70 minutes Facility 2021 38 41 $11,748 $5,483 46.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 26 35 $10,801 $4,914 45.5%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2021 15 15 $2,660 $2,485 93.4%
90674 Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free Office 2021 74 74 $3,407 $2,216 65.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 32 36 $4,336 $2,038 47.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 18 22 $3,682 $1,831 49.7%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2021 11 11 $1,760 $1,367 77.7%

About Dr. Daniel Roney, M.D

Dr. Daniel Roney, M.D is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487618690.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Roney, M.D has received a total of $14,346 in payments from pharmaceutical and medical device companies, with $2,144 received in 2024. These payments were reported across 971 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($14,270).

As a Medicare-enrolled provider, Roney has provided services to 5,039 Medicare beneficiaries, totaling 7,108 services with total Medicare billing of $378,364. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Kansas City, MO
  • Active Since 04/14/2006
  • Last Updated 08/24/2022
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1487618690

Products in Payments

  • FARXIGA (Drug) $907.88
  • VRAYLAR (Drug) $645.30
  • JARDIANCE (Drug) $637.27
  • Ozempic (Drug) $586.18
  • VYVANSE (Drug) $484.99
  • XARELTO (Drug) $430.33
  • TRULICITY (Drug) $364.62
  • UBRELVY (Drug) $361.81
  • STIOLTO RESPIMAT (Drug) $328.30
  • BREZTRI (Drug) $300.04
  • SYMBICORT (Drug) $286.56
  • Rybelsus (Drug) $283.93
  • CHANTIX (Drug) $263.21
  • NURTEC ODT (Drug) $241.90
  • LYRICA (Drug) $233.40
  • QULIPTA (Drug) $229.59
  • TRELEGY ELLIPTA (Drug) $216.85
  • LINZESS (Drug) $213.40
  • ENTRESTO (Drug) $204.12
  • ELIQUIS (Drug) $195.34

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Kansas City